Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pharmagreen Biotech's share price for the quarter that ended in Jun. 2023 was $0.00175. Pharmagreen Biotech's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 463.96 Mil. Therefore, Pharmagreen Biotech's market cap for the quarter that ended in Jun. 2023 was $0.81 Mil.
Pharmagreen Biotech's quarterly market cap
increased
from Dec. 2022 ($1.41 Mil) to Mar. 2023 ($2.18 Mil) but then
declined
from Mar. 2023 ($2.18 Mil) to Jun. 2023 ($0.81 Mil).
Pharmagreen Biotech's annual market cap
increased
from Sep. 2020 ($7.66 Mil) to Sep. 2021 ($10.48 Mil) but then
declined
from Sep. 2021 ($10.48 Mil) to Sep. 2022 ($4.42 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pharmagreen Biotech's Enterprise Value for Today is $0.62 Mil.
Pharmagreen Biotech (OTCPK:PHBI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pharmagreen Biotech Market Cap Related Terms
Pharmagreen Biotech Market Cap Historical Data
* Premium members only.
The historical data trend for Pharmagreen Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmagreen Biotech Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Pharmagreen Biotech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pharmagreen Biotech's Market Cap for the fiscal year that ended in Sep. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmagreen Biotech (PHBI) has a Market Cap of $0.62 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pharmagreen Biotech and its competitors.
Is Pharmagreen Biotech's Market Cap too high?
Pharmagreen Biotech's current Market Cap is $0.62 Mil. The Drug Manufacturers industry median Market Cap is 210.16. Pharmagreen Biotech's value of $0.62 Mil is 99.7% below this industry median.
How does Pharmagreen Biotech's Market Cap compare to DVLP and CSTF?
Pharmagreen Biotech's Market Cap of $0.62 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 210.16. Pharmagreen Biotech's value of $0.62 Mil is 99.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 210.16, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmagreen Biotech's current Market Cap of $0.62 Mil is 99.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pharmagreen Biotech and its competitors. For the Drug Manufacturers industry, the median Market Cap is 210.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmagreen Biotech's current Market Cap is $0.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagreen Biotech stock overvalued right now?
Pharmagreen Biotech (PHBI) has a current Market Cap of $0.62 Mil. The current Market Cap is $0.62 Mil and 99.7% below the Drug Manufacturers industry median of 210.16. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Pharmagreen Biotech (PHBI), the current Market Cap is $0.62 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHBI has been successfully added to your 